Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Re: Vitamin D--how much is enough, and is more better for your health?].
Holmøy T, Løken-Amsrud K, Kampman MT, Torkildsen Ø, Myhr KM. Holmøy T, et al. Among authors: loken amsrud k. Tidsskr Nor Laegeforen. 2014 May 27;134(10):1024-5. doi: 10.4045/tidsskr.14.0618. eCollection 2014 May 27. Tidsskr Nor Laegeforen. 2014. PMID: 24865723 Free article. Norwegian. No abstract available.
Impact of the environment on multiple sclerosis.
Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T. Løken-Amsrud KI, et al. Tidsskr Nor Laegeforen. 2015 May 19;135(9):856-60. doi: 10.4045/tidsskr.14.0751. eCollection 2015 May 19. Tidsskr Nor Laegeforen. 2015. PMID: 25991624 Free article. Review. English, Norwegian.
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T. Røsjø E, et al. Among authors: loken amsrud ki. J Neuroimmunol. 2014 Jun 15;271(1-2):60-5. doi: 10.1016/j.jneuroim.2014.03.014. Epub 2014 Mar 24. J Neuroimmunol. 2014. PMID: 24713402 Clinical Trial.
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T. Røsjø E, et al. Among authors: loken amsrud ki. J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11. J Neuroimmunol. 2015. PMID: 25773151
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N. Torkildsen O, et al. Among authors: loken amsrud ki. Ann Clin Transl Neurol. 2014 May;1(5):376-7. doi: 10.1002/acn3.56. Epub 2014 Apr 10. Ann Clin Transl Neurol. 2014. PMID: 25356407 Free PMC article. No abstract available.
19 results